ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 90 filers reported holding ATHIRA PHARMA INC in Q2 2021. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $68 | -31.3% | 33,600 | 0.0% | 0.01% | -25.0% |
Q2 2023 | $99 | +17.9% | 33,600 | 0.0% | 0.01% | +14.3% |
Q1 2023 | $84 | -15.2% | 33,600 | +8.0% | 0.01% | -22.2% |
Q4 2022 | $99 | -100.0% | 31,100 | +62.8% | 0.01% | -55.0% |
Q1 2022 | $258,000 | +3.6% | 19,100 | 0.0% | 0.02% | +5.3% |
Q4 2021 | $249,000 | +21.5% | 19,100 | -12.6% | 0.02% | +11.8% |
Q3 2021 | $205,000 | -8.5% | 21,850 | 0.0% | 0.02% | -5.6% |
Q2 2021 | $224,000 | – | 21,850 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 1,691,623 | $31,126,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 400,000 | $7,360,000 | 2.65% |
Logos Global Management LP | 1,010,812 | $18,599,000 | 1.82% |
S Squared Technology, LLC | 181,220 | $3,334,000 | 1.58% |
Avidity Partners Management LP | 1,677,845 | $30,872,000 | 0.85% |
Perceptive Advisors | 3,425,916 | $63,037,000 | 0.80% |
RTW INVESTMENTS, LP | 2,652,553 | $48,807,000 | 0.76% |
Sofinnova Investments, Inc. | 509,168 | $9,369,000 | 0.56% |
HighVista Strategies LLC | 32,062 | $590,000 | 0.44% |
DAFNA Capital Management LLC | 91,531 | $1,684,000 | 0.40% |